It was reported that FOXK2 inhibited cell proliferation and invasion in breast cancer, non-small cell lung cancer (NSCLC), clear-cell renal cell carcinoma, gastric cancer, and indicated favorable prognosis37–40. Here, FOXK2 is linked to non-small cell lung carcinoma.